Successful outcome of haemodialysis-induced pseudoporphyria after short-term oral N-acetylcysteine and switch to high-flux technique dialysis

Acta Dermato-Venereologica

Volumn 86, Issue 6, 2006, Pages 538-540

  Massone, Cesare ^a   Ambros Rudolph, Christina M ^a   Di Stefani, Alessandro ^a,b   Müllegger, Robert R ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Haemodialysis; High flux membrane; N acetylcysteine; Pseudoporphyria

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PORPHYRIN; RETINOID; STEROID;

AGED; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL EXAMINATION; CLINICAL FEATURE; FOLLOW UP; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MALE; PRIORITY JOURNAL; PSEUDOPORPHYRIA; SHORT COURSE THERAPY; TREATMENT OUTCOME; ULTRAVIOLET RADIATION; WALDENSTROEM MACROGLOBULINEMIA;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; AGED; ANTIVIRAL AGENTS; HAND DERMATOSES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PORPHYRIAS; RENAL DIALYSIS;

EID: 33845602691     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0156     Document Type: Article

References (14)

1. Gilchrest B, Rowe JW, Mihm MC Jr. Bullous dermatosis of hemodialysis. Ann Intern Med 1975; 83: 480-483.
2. Schanbacher CF, Vanness ER, Daoud MS, Tefferi A, Su WP. Pseudoporphyria: a clinical and biochemical study of 20 patients. Mayo Clin Proc 2001; 76: 488-492.
3. Hindmarsh JT, Oliveras L, Greenway DC. Plasma porphyrins in the porphyrias. Clin Chem 1999; 45: 1070-1076.
4. Chazot C, Chazot I, Charra B, Terrat JC, Vanel T, Calemard E, et al. Functional study of the hands among patients dialysed for more than 10 years. Nephrol Dialy Transplant 1993; 8: 347-351.
5. Silver EA, Silver AH, Silver DS, McCalmont TH. Pseudoporphyria induced by oral contraceptive pills. Arch Dermatol 2003; 139: 227-228.
6. Green JJ, Manders SM. Pseudoporphyria. J Am Acad Dermatol 2001; 44: 100-108.
7. Vadoud-Seyedi J, de Dobbeleer G, Simonart T. Treatment of haemodialysis-associated pseudoporphyria with N-acetylcysteine: report of two cases. Br J Dermatol 2000; 142: 580-581.
8. LaDuca JR, Bouman PH, Gaspari AA. Nonsteroidal anti-inflammatory drug-induced pseudoporphyria: a case series. J Cutan Med Surg 2002; 6: 320-326.
9. Kauppinen R. Porphyrias. Lancet 2005; 365: 241-252.
10. Sassa S. The porphyrias. Photodermatol Photoimmunol Photomed 2002; 18: 56-67.
11. Tremblay JF, Veilleux B. Pseudoporphyria associated with hemodialysis treated with N-acetylcysteine. J Am Acad Dermatol 2003; 49: 1189-1190.
12. Shieh S, Cohen JL, Lim HW. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. J Am Acad Dermatol 2000; 42: 645-652.
13. Bordoni V, Piroddi M, Galli F, de Cal M, Bonello M, Dimitri P, et al. Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif 2006; 24: 149-156.
14. Schindler R, Ertl T, Beck W, Lepenies J, Boenisch O, Oppermann M, et al. Reduced cytokine induction and removal of complement products with synthetic hemodialysis membranes. Blood Purif 2005; 24: 203-211.